CD8A and cancer: In the ovalbumin model antigen system, assays for antigen presentation and T cell proliferation/maturation demonstrated that miR-96-5p-enhanced removal of cancer cells led to increased antigen presentation and priming of T cells, particularly CD8+ T cells.